You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中紀委嚴查醫療領域利益輸送
中央紀委國家監委發文指出,醫藥行業風腐問題不斷變異升級,近期國家市監總局通報5宗反不正當競爭專項執法行動典型案例,其中2宗發生在醫療衛生行業,涉及以科研贊助、支付回扣形式進行的商業賄賂事件。 通報指,隨著對商業賄賂案件查處力度不斷加大,有醫藥企業採取更為隱蔽、複雜的手段,為其賄賂行為披上「合法外衣」,例如以贊助科研經費、學術會議費等名義進行不法利益輸送,以及在醫藥購銷環節醫院工作向人員提供回扣、通過生產環節虛抬藥品價格、流通環節虛假交易等。 文章提到,醫療領域專業性較強,相關違紀違法行為具有一定隱蔽性,問題不易被察覺,當局在強化對醫療機構高層、重點崗位、醫療設備採購等方面監督時,應採取行之有效的駐點監督、交叉延伸巡察等手段。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account